NCT00005036 - Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter

Enrollment

560

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

December 31, 2006

Conditions

Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon CancerRecurrent Rectal CancerSignet Ring Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the RectumStage IIIA Colon CancerStage IIIA Rectal CancerStage IIIB Colon CancerStage IIIB Rectal CancerStage IIIC Colon CancerStage IIIC Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal Cancer

Interventions

DRUG

irinotecan hydrochloride

Given IV

DRUG

oxaliplatin

Given IV

DRUG

leucovorin calcium

Given IV

DRUG

fluorouracil

Given IV

PROCEDURE

quality-of-life assessment

Ancillary studies

Trial Locations (1)

55905

North Central Cancer Treatment Group, Rochester

All Listed Sponsors

collaborator

SWOG Cancer Research Network

NETWORK

collaborator

Eastern Cooperative Oncology Group

NETWORK

lead

National Cancer Institute (NCI)

NIH